| Product Code: ETC7644904 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Israel saw a shift in the concentration of antibody imports, with a notable increase in market share from top exporting countries including Germany, USA, Italy, Slovenia, and the UK. The Herfindahl-Hirschman Index (HHI) reflected this change, moving from low concentration in 2023 to high concentration in 2024. This shift coincided with a negative Compound Annual Growth Rate (CAGR) of -7.31% from 2020 to 2024, and a significant decline in the growth rate from 2023 to 2024 at -31.98%. These trends suggest a dynamic market landscape for antibody imports in Israel, potentially influenced by various factors impacting the industry.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Antibodies Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Antibodies Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Antibodies Market - Industry Life Cycle |
3.4 Israel Antibodies Market - Porter's Five Forces |
3.5 Israel Antibodies Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Israel Antibodies Market Revenues & Volume Share, By Antibodes Type, 2021 & 2031F |
3.7 Israel Antibodies Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 Israel Antibodies Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.9 Israel Antibodies Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.10 Israel Antibodies Market Revenues & Volume Share, By End use, 2021 & 2031F |
4 Israel Antibodies Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Israel Antibodies Market Trends |
6 Israel Antibodies Market, By Types |
6.1 Israel Antibodies Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Israel Antibodies Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Israel Antibodies Market Revenues & Volume, By Primary, 2021- 2031F |
6.1.4 Israel Antibodies Market Revenues & Volume, By Secondary, 2021- 2031F |
6.2 Israel Antibodies Market, By Antibodes Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Antibodies Market Revenues & Volume, By Monoclonal Antibodies, 2021- 2031F |
6.2.3 Israel Antibodies Market Revenues & Volume, By Polyclonal Antibodies, 2021- 2031F |
6.3 Israel Antibodies Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 Israel Antibodies Market Revenues & Volume, By Immunohistochemistry, 2021- 2031F |
6.3.3 Israel Antibodies Market Revenues & Volume, By Immunofluorescence, 2021- 2031F |
6.3.4 Israel Antibodies Market Revenues & Volume, By Western Blotting, 2021- 2031F |
6.3.5 Israel Antibodies Market Revenues & Volume, By Flow Cytometry, 2021- 2031F |
6.3.6 Israel Antibodies Market Revenues & Volume, By Immunoprecipitation, 2021- 2031F |
6.3.7 Israel Antibodies Market Revenues & Volume, By ELISA, 2021- 2031F |
6.4 Israel Antibodies Market, By Source |
6.4.1 Overview and Analysis |
6.4.2 Israel Antibodies Market Revenues & Volume, By Mouse, 2021- 2031F |
6.4.3 Israel Antibodies Market Revenues & Volume, By Rabbit, 2021- 2031F |
6.4.4 Israel Antibodies Market Revenues & Volume, By Goat, 2021- 2031F |
6.4.5 Israel Antibodies Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Israel Antibodies Market, By Application |
6.5.1 Overview and Analysis |
6.5.2 Israel Antibodies Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.5.3 Israel Antibodies Market Revenues & Volume, By Immunology, 2021- 2031F |
6.5.4 Israel Antibodies Market Revenues & Volume, By Oncology, 2021- 2031F |
6.5.5 Israel Antibodies Market Revenues & Volume, By Stem Cells, 2021- 2031F |
6.5.6 Israel Antibodies Market Revenues & Volume, By Neurobiology, 2021- 2031F |
6.5.7 Israel Antibodies Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Israel Antibodies Market, By End use |
6.6.1 Overview and Analysis |
6.6.2 Israel Antibodies Market Revenues & Volume, By Academic & Research Institutes, 2021- 2031F |
6.6.3 Israel Antibodies Market Revenues & Volume, By Contract Research Organizations, 2021- 2031F |
6.6.4 Israel Antibodies Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
7 Israel Antibodies Market Import-Export Trade Statistics |
7.1 Israel Antibodies Market Export to Major Countries |
7.2 Israel Antibodies Market Imports from Major Countries |
8 Israel Antibodies Market Key Performance Indicators |
9 Israel Antibodies Market - Opportunity Assessment |
9.1 Israel Antibodies Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Israel Antibodies Market Opportunity Assessment, By Antibodes Type, 2021 & 2031F |
9.3 Israel Antibodies Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.4 Israel Antibodies Market Opportunity Assessment, By Source, 2021 & 2031F |
9.5 Israel Antibodies Market Opportunity Assessment, By Application, 2021 & 2031F |
9.6 Israel Antibodies Market Opportunity Assessment, By End use, 2021 & 2031F |
10 Israel Antibodies Market - Competitive Landscape |
10.1 Israel Antibodies Market Revenue Share, By Companies, 2024 |
10.2 Israel Antibodies Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here